RIM
RGNX icon

RS Investment Management’s Regenxbio RGNX Stock Holding History

RS Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$4.54M Sell
566,869
-411,534
-42% -$4.57M 0.05% 270
2016
Q1 		$10.6M Buy
978,403
+231,811
+31% +$2.97M 0.1% 238
2015
Q4 		$12.4M Buy
746,592
+75,810
+11% +$1.5M 0.11% 217
2015
Q3 		$14.8M Buy
+670,782
New +$17.1M 0.13% 205

Other funds holding RGNX

BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RS Investment Management's RGNX Position: Q2 2016 in Review

RS Investment Management reduced its Regenxbio (RGNX) stake by 42% in Q2 2016, selling an estimated $4.57M and leaving 566,869 shares worth $4.54M. The position accounts for 0.05% of the portfolio, ranked #270.

RS Investment Management first reported a position in RGNX in Q3 2015 and has held it in 4 quarters since. The position peaked at $14.8M in Q3 2015. 69 funds tracked by Wall St. Rank hold RGNX as of Q2 2016.

  • RS Investment Management held 566,869 shares of Regenxbio worth $4.54M as of Q2 2016.
  • RS Investment Management sold 411,534 Regenxbio shares in Q2 2016, an estimated $4.57M.
  • Regenxbio made up 0.05% of RS Investment Management's portfolio in Q2 2016, its #270 holding.
  • RS Investment Management first reported a position in Regenxbio in Q3 2015 and has held it in 4 quarters since.
  • RS Investment Management's Regenxbio position peaked at $14.8M in Q3 2015.
  • 69 funds tracked by Wall St. Rank held Regenxbio as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.